MedTrace Logo

Viatorr CX Case-control Study for Complications of Portal Hypertension

NCT03083925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-04-24

No results posted yet for this study

Summary

To evaluate the clinical benefits in the patients receiving Viatorr CX over a period of 12 months of structured Follow-up (before TIPS, at TIPS, 1 week after TIPS, at 6 weeks, 4 months, 6 months, 9 months, 12 months), regarding clinical endpoints, such as HE, readmission, liver injury, cardiac function, response to TIPS and the passive expansion of the stents in real life.

Conditions

  • Liver Cirrhoses
  • Portal Hypertension

Interventions

DEVICE

TIPS

Transjugular Intrahepatic Portosystemic Shunt

Sponsors & Collaborators

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Jonel Trebicka, MD, PhD · Laboratory for Liver Fibrosis and Portal Hypertension

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-23
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03083925 on ClinicalTrials.gov